ArticleBMC infectious diseases2026

The LEN4PrEP study: protocol for a phase 3B, non-randomised clinical trial integrating lenacapavir PrEP within multi-product HIV prevention services in primary care clinics in South Africa.

Roisin E Drysdale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.